+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Metabolomics Market Research Report by Product & Service, Indication, Application, End User, State - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - United States Forecast 2023-2030

  • PDF Icon

    Report

  • 127 Pages
  • January 2023
  • Region: United States
  • 360iResearch™
  • ID: 5722316
The United States Metabolomics Market is projected to grow with a significant CAGR in the forecast period. Economic development and substantial infrastructure development have constituted regional revenue generation. Further, the patterns associated with domestic production, import and export, and consumption have helped market participants to analyze and capitalize on potential opportunities. Besides, the qualitative and quantitative parameters provided in the report with detailed analysis highlights the driving and restraining factors of the United States Metabolomics Market.

Cumulative Impact of COVID-19:

COVID-19 is an unprecedented global public health emergency that affected almost every industry, and the long-term impacts are projected to reflect on the growth of various end-use industries during the forecast period. This ongoing research amplifies the research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19, considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The dedicated section in the report uncovers a detailed analysis of the impact of COVID-19 and its subsequent variant outbreaks on demand, supply, price, and vendor uptake and provides recommendations for sustainable outcomes. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the United States Metabolomics Market.

Cumulative Impact of Russia-Ukraine Conflict:

The publisher continuously monitors and update reports considering unceasing political and economic uncertainty due to the Russia-Ukraine Conflict. Negative impacts are globally foreseen, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected people’s lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on Ukraine and reverberate harsh long-term effects on Russia. The report uncovers the implications for demand-supply balances, pressure on pricing variants, impact on import/export and trading, and short-term recommendations to the United States Metabolomics Market considering the current update on the conflict and its global responses.

Cumulative Impact of High Inflation:

The high inflation in developed economies globally has resulted in an overall price surge over the past two years. The cumulatively eroding overall purchasing power is expected to impact developing economies significantly and is considered helpful in numerous ways. The report uncovers the effect of high inflation on the long-term performance of the global economy and provides details on fiscal policies measuring and reducing its short-term impacts on demand/supply, cash flow, and currency exchange. The United States Metabolomics Market report delivers the high inflation expectation considering the related impact from cost-push and demand-pull inflation.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make better decisions. In this report, the years 2018 and 2021 are considered as historical years, 2022 as the base year, 2023 as the estimated year, and years from 2024 to 2030 are considered as the forecast period.

Market Segmentation & Coverage:

The report on the United States Metabolomics Market identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. The market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for your market plan. This research report categorizes the United States Metabolomics Market in order to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Product & Service, the market is studied across Bioinformatics Tools & Services and Metabolomics Instruments. The Bioinformatics Tools & Services is is further studied across Bioinformatics Services and Bioinformatics Tools & Databases. The Metabolomics Instruments is is further studied across Detection Tools and Separation Tools. The Detection Tools is is further studied across Mass Spectrometry, Nuclear Magnetic Resonance Spectroscopy, and Surface-Based Mass Analysis. The Separation Tools is is further studied across Capillary Electrophoresis, Gas Chromatography, High-performance Liquid Chromatography, and Ultra-performance Liquid Chromatography.
  • Based on Indication, the market is studied across Cancer, Cardiovascular Disorders, Inborn Errors of Metabolism, Metabolic Disorders, and Neurological Disorders.
  • Based on Application, the market is studied across Biomarker discovery, Drug discovery, Functional Genomics, Nutrigenomics, Personalized medicine, and Toxicology testing.
  • Based on End User, the market is studied across Academic & Research Institutes, Contract Research Organizations, and Pharmaceutical & Biotechnology Companies.
  • Based on State, the market is studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes vendors in the United States Metabolomics Market. based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinder, N: Niche, and V: Vital). The United States Metabolomics Market FPNV Positioning Matrix representation/visualization further aids businesses in better decision-making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market, providing the idea of revenue generation into the overall market compared to other vendors in the space. This provides insights on vendors performance in terms of revenue generation and customer base compared to others. The United States Metabolomics Market Share Analysis offers an idea of the size and competitiveness of the vendors for the base year. The outcome reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various strategies for business growth adopted by the vendors. The news in this section covers valuable insights at various stages while keeping up with the business and engaging stakeholders in the economic debate. The United States Metabolomics Market Competitive Scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected helps vendors understand the gaps in the marketplace and competitor’s strengths and weaknesses, providing insights to enhance products and services.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the United States Metabolomics Market, including Afekta Technologies Ltd., Bio-Rad Laboratories, Inc., Biocrates Life Science AG, Bruker Corporation, Danaher Corporation, General Electric Company, Hitachi High-Tech Corporation, Human Metabolome Technologies America Inc., Japan Spectroscopic Company, Kore Technology Limited, LECO Corporation, Merck KGaA, SCION Instruments UK Ltd, Shimadzu Corporation, and Waters Corporation.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the United States Metabolomics Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States Metabolomics Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Metabolomics Market?
4. What is the competitive strategic window for opportunities in the United States Metabolomics Market?
5. What are the technology trends and regulatory frameworks in the United States Metabolomics Market?
6. What is the market share of the leading vendors in the United States Metabolomics Market?
7. What modes and strategic moves are considered suitable for entering the United States Metabolomics Market?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Favorable government fundings and initiatives for drug discovery and drug developments in the United States
5.1.1.2. Expansion of healthcare sectors with growing demand for personalized medications
5.1.2. Restraints
5.1.2.1. Concern regarding the complex data monitoring and data processing
5.1.3. Opportunities
5.1.3.1. Emergence of novel and innovative technologies coupled with vast presence of market manufactures
5.1.3.2. Ongoing investments in research and developments areas of healthcare in the United States
5.1.4. Challenges
5.1.4.1. Dearth of skilled professionals in the healthcare sectors
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of Russia-Ukraine Conflict
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Threat of Substitutes
5.5.4. Threat of Substitutes
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
5.8. Client Customization

6. Metabolomics Market, by Product & Service
6.1. Introduction
6.2. Bioinformatics Tools & Services
6.3.1. Bioinformatics Services
6.3.2. Bioinformatics Tools & Databases
6.3. Metabolomics Instruments
6.4.1. Detection Tools
6.4.2.1. Mass Spectrometry
6.4.2.2. Nuclear Magnetic Resonance Spectroscopy
6.4.2.3. Surface-Based Mass Analysis
6.4.2. Separation Tools
6.4.3.1. Capillary Electrophoresis
6.4.3.2. Gas Chromatography
6.4.3.3. High-performance Liquid Chromatography
6.4.3.4. Ultra-performance Liquid Chromatography

7. Metabolomics Market, by Indication
7.1. Introduction
7.2. Cancer
7.3. Cardiovascular Disorders
7.4. Inborn Errors of Metabolism
7.5. Metabolic Disorders
7.6. Neurological Disorders

8. Metabolomics Market, by Application
8.1. Introduction
8.2. Biomarker discovery
8.3. Drug discovery
8.4. Functional Genomics
8.5. Nutrigenomics
8.6. Personalized medicine
8.7. Toxicology testing

9. Metabolomics Market, by End User
9.1. Introduction
9.2. Academic & Research Institutes
9.3. Contract Research Organizations
9.4. Pharmaceutical & Biotechnology Companies

10. California Metabolomics Market
10.1. Introduction

11. Florida Metabolomics Market
11.1. Introduction

12. Illinois Metabolomics Market
12.1. Introduction

13. New York Metabolomics Market
13.1. Introduction

14. Ohio Metabolomics Market
14.1. Introduction

15. Pennsylvania Metabolomics Market
15.1. Introduction

16. Texas Metabolomics Market
16.1. Introduction

17. Competitive Landscape
17.1. FPNV Positioning Matrix
17.1.1. Quadrants
17.1.2. Business Strategy
17.1.3. Product Satisfaction
17.2. Market Ranking Analysis, By Key Player
17.3. Market Share Analysis, By Key Player
17.4. Product Portfolio Analysis, By Key Player
17.5. Competitive Scenario
17.5.1. Merger & Acquisition
17.5.2. Agreement, Collaboration, & Partnership
17.5.3. New Product Launch & Enhancement
17.5.4. Investment & Funding
17.5.5. Award, Recognition, & Expansion

18. Company Usability Profiles
18.1. Afekta Technologies Ltd.
18.2. Bio-Rad Laboratories, Inc.
18.3. Biocrates Life Science AG
18.4. Bruker Corporation
18.5. Danaher Corporation
18.6. General Electric Company
18.7. Hitachi High-Tech Corporation
18.8. Human Metabolome Technologies America Inc.
18.9. Japan Spectroscopic Company
18.10. Kore Technology Limited
18.11. LECO Corporation
18.12. Merck KGaA
18.13. SCION Instruments UK Ltd
18.14. Shimadzu Corporation
18.15. Waters Corporation

19. Appendix
19.1. Discussion Guide
19.2. License & Pricing

List of Figures
FIGURE 1. UNITED STATES METABOLOMICS MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES METABOLOMICS MARKET SIZE, 2022 VS 2030
FIGURE 3. UNITED STATES METABOLOMICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. UNITED STATES METABOLOMICS MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 5. UNITED STATES METABOLOMICS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. UNITED STATES METABOLOMICS MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2030
FIGURE 7. UNITED STATES METABOLOMICS MARKET DYNAMICS
FIGURE 8. UNITED STATES METABOLOMICS MARKET PORTER’S FIVE FORCES ANALYSIS
FIGURE 9. UNITED STATES METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2022 VS 2030 (%)
FIGURE 10. UNITED STATES METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. UNITED STATES METABOLOMICS MARKET COMPETITIVE STRATEGIC WINDOW, BY PRODUCT & SERVICE, 2030
FIGURE 12. UNITED STATES METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
FIGURE 13. UNITED STATES METABOLOMICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
FIGURE 14. UNITED STATES METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & DATABASES, 2018-2030 (USD MILLION)
FIGURE 15. UNITED STATES METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
FIGURE 16. UNITED STATES METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
FIGURE 17. UNITED STATES METABOLOMICS MARKET SIZE, BY MASS SPECTROMETRY , 2018-2030 (USD MILLION)
FIGURE 18. UNITED STATES METABOLOMICS MARKET SIZE, BY NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY, 2018-2030 (USD MILLION)
FIGURE 19. UNITED STATES METABOLOMICS MARKET SIZE, BY SURFACE-BASED MASS ANALYSIS, 2018-2030 (USD MILLION)
FIGURE 20. UNITED STATES METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
FIGURE 21. UNITED STATES METABOLOMICS MARKET SIZE, BY CAPILLARY ELECTROPHORESIS, 2018-2030 (USD MILLION)
FIGURE 22. UNITED STATES METABOLOMICS MARKET SIZE, BY GAS CHROMATOGRAPHY, 2018-2030 (USD MILLION)
FIGURE 23. UNITED STATES METABOLOMICS MARKET SIZE, BY HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY, 2018-2030 (USD MILLION)
FIGURE 24. UNITED STATES METABOLOMICS MARKET SIZE, BY ULTRA-PERFORMANCE LIQUID CHROMATOGRAPHY, 2018-2030 (USD MILLION)
FIGURE 25. UNITED STATES METABOLOMICS MARKET SIZE, BY INDICATION, 2022 VS 2030 (%)
FIGURE 26. UNITED STATES METABOLOMICS MARKET SIZE, BY INDICATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 27. UNITED STATES METABOLOMICS MARKET COMPETITIVE STRATEGIC WINDOW, BY INDICATION, 2030
FIGURE 28. UNITED STATES METABOLOMICS MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
FIGURE 29. UNITED STATES METABOLOMICS MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2018-2030 (USD MILLION)
FIGURE 30. UNITED STATES METABOLOMICS MARKET SIZE, BY INBORN ERRORS OF METABOLISM, 2018-2030 (USD MILLION)
FIGURE 31. UNITED STATES METABOLOMICS MARKET SIZE, BY METABOLIC DISORDERS, 2018-2030 (USD MILLION)
FIGURE 32. UNITED STATES METABOLOMICS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
FIGURE 33. UNITED STATES METABOLOMICS MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
FIGURE 34. UNITED STATES METABOLOMICS MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 35. UNITED STATES METABOLOMICS MARKET COMPETITIVE STRATEGIC WINDOW, BY APPLICATION, 2030
FIGURE 36. UNITED STATES METABOLOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2030 (USD MILLION)
FIGURE 37. UNITED STATES METABOLOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
FIGURE 38. UNITED STATES METABOLOMICS MARKET SIZE, BY FUNCTIONAL GENOMICS, 2018-2030 (USD MILLION)
FIGURE 39. UNITED STATES METABOLOMICS MARKET SIZE, BY NUTRIGENOMICS, 2018-2030 (USD MILLION)
FIGURE 40. UNITED STATES METABOLOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
FIGURE 41. UNITED STATES METABOLOMICS MARKET SIZE, BY TOXICOLOGY TESTING, 2018-2030 (USD MILLION)
FIGURE 42. UNITED STATES METABOLOMICS MARKET SIZE, BY END USER, 2022 VS 2030 (%)
FIGURE 43. UNITED STATES METABOLOMICS MARKET SIZE, BY END USER, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 44. UNITED STATES METABOLOMICS MARKET COMPETITIVE STRATEGIC WINDOW, BY END USER, 2030
FIGURE 45. UNITED STATES METABOLOMICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
FIGURE 46. UNITED STATES METABOLOMICS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
FIGURE 47. UNITED STATES METABOLOMICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
FIGURE 48. CALIFORNIA METABOLOMICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 49. FLORIDA METABOLOMICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 50. ILLINOIS METABOLOMICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 51. NEW YORK METABOLOMICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 52. OHIO METABOLOMICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 53. PENNSYLVANIA METABOLOMICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 54. TEXAS METABOLOMICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 55. UNITED STATES METABOLOMICS MARKET: FPNV POSITIONING MATRIX, 2022
FIGURE 56. UNITED STATES METABOLOMICS MARKET SHARE, BY KEY PLAYER, 2022
FIGURE 57. UNITED STATES METABOLOMICS MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2022


List of Tables
TABLE 1. UNITED STATES METABOLOMICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. UNITED STATES METABOLOMICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. UNITED STATES METABOLOMICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 5. UNITED STATES METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 6. UNITED STATES METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
TABLE 7. UNITED STATES METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, BY STATE, 2018-2030 (USD MILLION)
TABLE 8. UNITED STATES METABOLOMICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
TABLE 9. UNITED STATES METABOLOMICS MARKET SIZE, BY BIOINFORMATICS SERVICES, BY STATE, 2018-2030 (USD MILLION)
TABLE 10. UNITED STATES METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & DATABASES, 2018-2030 (USD MILLION)
TABLE 11. UNITED STATES METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & DATABASES, BY STATE, 2018-2030 (USD MILLION)
TABLE 12. UNITED STATES METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 13. UNITED STATES METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, BY STATE, 2018-2030 (USD MILLION)
TABLE 14. UNITED STATES METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
TABLE 15. UNITED STATES METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, BY STATE, 2018-2030 (USD MILLION)
TABLE 16. UNITED STATES METABOLOMICS MARKET SIZE, BY MASS SPECTROMETRY , 2018-2030 (USD MILLION)
TABLE 17. UNITED STATES METABOLOMICS MARKET SIZE, BY MASS SPECTROMETRY , BY STATE, 2018-2030 (USD MILLION)
TABLE 18. UNITED STATES METABOLOMICS MARKET SIZE, BY NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY, 2018-2030 (USD MILLION)
TABLE 19. UNITED STATES METABOLOMICS MARKET SIZE, BY NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY, BY STATE, 2018-2030 (USD MILLION)
TABLE 20. UNITED STATES METABOLOMICS MARKET SIZE, BY SURFACE-BASED MASS ANALYSIS, 2018-2030 (USD MILLION)
TABLE 21. UNITED STATES METABOLOMICS MARKET SIZE, BY SURFACE-BASED MASS ANALYSIS, BY STATE, 2018-2030 (USD MILLION)
TABLE 22. UNITED STATES METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
TABLE 23. UNITED STATES METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, BY STATE, 2018-2030 (USD MILLION)
TABLE 24. UNITED STATES METABOLOMICS MARKET SIZE, BY CAPILLARY ELECTROPHORESIS, 2018-2030 (USD MILLION)
TABLE 25. UNITED STATES METABOLOMICS MARKET SIZE, BY CAPILLARY ELECTROPHORESIS, BY STATE, 2018-2030 (USD MILLION)
TABLE 26. UNITED STATES METABOLOMICS MARKET SIZE, BY GAS CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 27. UNITED STATES METABOLOMICS MARKET SIZE, BY GAS CHROMATOGRAPHY, BY STATE, 2018-2030 (USD MILLION)
TABLE 28. UNITED STATES METABOLOMICS MARKET SIZE, BY HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 29. UNITED STATES METABOLOMICS MARKET SIZE, BY HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY, BY STATE, 2018-2030 (USD MILLION)
TABLE 30. UNITED STATES METABOLOMICS MARKET SIZE, BY ULTRA-PERFORMANCE LIQUID CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 31. UNITED STATES METABOLOMICS MARKET SIZE, BY ULTRA-PERFORMANCE LIQUID CHROMATOGRAPHY, BY STATE, 2018-2030 (USD MILLION)
TABLE 32. UNITED STATES METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 33. UNITED STATES METABOLOMICS MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES METABOLOMICS MARKET SIZE, BY CANCER, BY STATE, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES METABOLOMICS MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES METABOLOMICS MARKET SIZE, BY CARDIOVASCULAR DISORDERS, BY STATE, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES METABOLOMICS MARKET SIZE, BY INBORN ERRORS OF METABOLISM, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES METABOLOMICS MARKET SIZE, BY INBORN ERRORS OF METABOLISM, BY STATE, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES METABOLOMICS MARKET SIZE, BY METABOLIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES METABOLOMICS MARKET SIZE, BY METABOLIC DISORDERS, BY STATE, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES METABOLOMICS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES METABOLOMICS MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY STATE, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES METABOLOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES METABOLOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, BY STATE, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES METABOLOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES METABOLOMICS MARKET SIZE, BY DRUG DISCOVERY, BY STATE, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES METABOLOMICS MARKET SIZE, BY FUNCTIONAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES METABOLOMICS MARKET SIZE, BY FUNCTIONAL GENOMICS, BY STATE, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES METABOLOMICS MARKET SIZE, BY NUTRIGENOMICS, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES METABOLOMICS MARKET SIZE, BY NUTRIGENOMICS, BY STATE, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES METABOLOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES METABOLOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, BY STATE, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES METABOLOMICS MARKET SIZE, BY TOXICOLOGY TESTING, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES METABOLOMICS MARKET SIZE, BY TOXICOLOGY TESTING, BY STATE, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES METABOLOMICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES METABOLOMICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY STATE, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES METABOLOMICS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES METABOLOMICS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY STATE, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES METABOLOMICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES METABOLOMICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY STATE, 2018-2030 (USD MILLION)
TABLE 63. CALIFORNIA METABOLOMICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 64. CALIFORNIA METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 65. CALIFORNIA METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 66. CALIFORNIA METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. CALIFORNIA METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 68. FLORIDA METABOLOMICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 69. FLORIDA METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 70. FLORIDA METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 71. FLORIDA METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 72. FLORIDA METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 73. ILLINOIS METABOLOMICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 74. ILLINOIS METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 75. ILLINOIS METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 76. ILLINOIS METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77. ILLINOIS METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 78. NEW YORK METABOLOMICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 79. NEW YORK METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 80. NEW YORK METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 81. NEW YORK METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 82. NEW YORK METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 83. OHIO METABOLOMICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 84. OHIO METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 85. OHIO METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 86. OHIO METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. OHIO METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 88. PENNSYLVANIA METABOLOMICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 89. PENNSYLVANIA METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 90. PENNSYLVANIA METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 91. PENNSYLVANIA METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. PENNSYLVANIA METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 93. TEXAS METABOLOMICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 94. TEXAS METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 95. TEXAS METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 96. TEXAS METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 97. TEXAS METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 98. UNITED STATES METABOLOMICS MARKET: FPNV POSITIONING MATRIX - SCORES, 2022
TABLE 99. UNITED STATES METABOLOMICS MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2022
TABLE 100. UNITED STATES METABOLOMICS MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2022
TABLE 101. UNITED STATES METABOLOMICS MARKET RANKING, BY KEY PLAYER, 2022
TABLE 102. UNITED STATES METABOLOMICS MARKET SHARE, BY KEY PLAYER, 2022
TABLE 103. UNITED STATES METABOLOMICS MARKET PRODUCT PORTFOLIO ANALYSIS, BY KEY PLAYER, 2022
TABLE 104. UNITED STATES METABOLOMICS MARKET MERGER & ACQUISITION
TABLE 105. UNITED STATES METABOLOMICS MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 106. UNITED STATES METABOLOMICS MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 107. UNITED STATES METABOLOMICS MARKET INVESTMENT & FUNDING
TABLE 108. UNITED STATES METABOLOMICS MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 109. UNITED STATES METABOLOMICS MARKET: LICENSE & PRICING

Companies Mentioned

  • Afekta Technologies Ltd.
  • Bio-Rad Laboratories, Inc.
  • Biocrates Life Science AG
  • Bruker Corporation
  • Danaher Corporation
  • General Electric Company
  • Hitachi High-Tech Corporation
  • Human Metabolome Technologies America Inc.
  • Japan Spectroscopic Company
  • Kore Technology Limited
  • LECO Corporation
  • Merck KGaA
  • SCION Instruments UK Ltd
  • Shimadzu Corporation
  • Waters Corporation

Methodology

Loading
LOADING...